Research
Citigroup Downgrades Accendra Health to Neutral From Buy, Adjusts PT to $1.50 From $4.50
$ACH
$ACH
2 stories mentioning ACHUpdated just now
Every FINWIRES story that references ACH, newest first.
Research
Baird Downgrades Accendra Health to Neutral From Outperform, Adjusts PT to $1.50 From $6
$ACH
